LinkDoc Secures Strategic Investment from Ali Health to Build China's Comprehensive Oncology Patient Care Platform

VCBeat has learned that LinkDoc recently announced it has received a strategic investment from AliHealth. The two parties will jointly build a patient-centric, technology-driven service platform covering the entire disease journey for cancer patients in China. They will actively explore innovative online service models for specialty oncology medications and establish an integrated online-offline ecosystem for specialized oncology medical services, thereby providing cancer patients with high-quality healthcare solutions spanning the full disease continuum—from clinical care to pharmaceutical treatment.

Due to population aging, environmental changes, and shifts in lifestyle habits, the incidence of malignant tumors is steadily rising, posing a significant threat to public health. Data from the National Health Commission of China shows that there are over 3.5 million new cancer cases and more than 2 million cancer-related deaths annually in the country, highlighting a severe situation for prevention and control. There is an urgent demand within the industry for innovative drugs and treatment regimens in the field of oncology.

Amid an environment that encourages innovation and development in the healthcare industry, Alibaba Health has proactively expanded its strategic footprint to meet the diverse healthcare needs of a broader patient population. Deeply committed to the “Internet + Healthcare” model, Alibaba Health is building a trustworthy and inclusive medical service system. By implementing a strategy centered on “quality medicines, renowned physicians, and reliable safeguards,” it leverages internet-based models and technological innovations to advance research, diagnosis, and treatment for major diseases, as well as to foster growth in fields such as genetic testing and biological vaccines.

This strategic investment in LinkDoc represents Alibaba Health’s new initiative in the field of major diseases, underscoring its commitment to leveraging innovative internet technologies to support serious medical care.

It is reported that LinkDoc has long been committed to the research, development, and application of big data and artificial intelligence in oncology. Guided by its mission, “Care Data Care Life,” the company provides comprehensive big data and AI solutions to stakeholders across the pharmaceutical and healthcare industries. Its core business activities currently include real-world studies of pharmaceuticals, patient health management, and patient recruitment services, with a particular focus on delivering solutions for major diseases, notably cancer and rare diseases.

Following this round of financing, LinkDoc will leverage its advantages in data governance, assisted diagnosis and treatment, research services, patient management, physician engagement, and drug distribution within the oncology vertical. Always patient-centric, the company is committed to integrating online and offline resources to establish a closed-loop service ecosystem, thereby benefiting more patients.

LinkDoc and Alibaba Health have entered into a strategic partnership to leverage their respective strengths accumulated over the years in the field of major diseases. By integrating resources across the Alibaba Health platform, LinkDoc Internet Hospital, and Oncology Patient Service Centers, they aim to provide users with more precise, convenient, and comprehensive services for critical illnesses. This collaboration seeks to enhance disease treatment and service standards, advancing both parties toward the shared goal of overcoming complex medical challenges and extending human lifespan.